Publications by authors named "Gary Barnette"

Claim this Profile
O
Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis.
K Gary Barnette, Michael S Gordon, Domingo Rodriguez, T Gary Bird, Alan Skolnick

NEJM Evid· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.
Mark C Markowski, Ronald Tutrone, Christopher Pieczonka, K Gary Barnette, Robert H Getzenberg

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
Samir S Taneja, Ronald Morton, Gary Barnette, Paul Sieber, Michael L Hancock

J Clin Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
Matthew R Smith, Ronald A Morton, K Gary Barnette, Paul R Sieber, S Bruce Malkowicz

J Urol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer.
Alicia K Morgans, Michael L Hancock, K Gary Barnette, Mitchell S Steiner, Ronald A Morton

J Urol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer.
Philip J Saylor, Ronald A Morton, Michael L Hancock, K Gary Barnette, Mitchell S Steiner

J Urol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
Matthew R Smith, Ronald A Morton, K Gary Barnette, Paul R Sieber, S Bruce Malkowicz

J Urol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.
Matthew R Smith, S Bruce Malkowicz, Franklin Chu, John Forrest, Paul Sieber, K Gary Barnette

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.
Samir S Taneja, Matthew R Smith, James T Dalton, Sharan Raghow, Gary Barnette

Expert Opin Investig Drugs· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis